Recombinant Escherichia coli O81 Peptide chain release factor 1 (prfA)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the available format, but you can specify your preferred format when ordering.
Lead Time
Delivery times vary by purchase method and location. Contact your local distributor for specifics. Proteins are shipped with blue ice packs by default. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Default glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag preference, please let us know.
Synonyms
prfA; ECED1_1359; Peptide chain release factor 1; RF-1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-360
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Escherichia coli O81 (strain ED1a)
Target Names
prfA
Target Protein Sequence
MKPSIVAKLE ALHERHEEVQ ALLGDAQTIA DQERFRALSR EYAQLSDVSR CFTDWQQVQE DIETAQMMLD DPEMREMAQD ELREAKEKSE QLEQQLQVLL LPKDPDDERN AFLEVRAGTG GDEAALFAGD LFRMYSRYAE ARRWRVEIMS ASEGEHGGYK EIIAKISGDG VYGRLKFESG GHRVQRVPAT ESQGRIHTSA CTVAVMPELP DAELPDINPA DLRIDTFRSS GAGGQHVNTT DSAIRITHLP TGIVVECQDE RSQHKNKAKA LSVLGARIHA AEMAKRQQAE ASTRRNLLGS GDRSDRNRTY NFPQGRVTDH RINLTLYCLD EVMEGKLDML IEPIIQEHQA DQLAALSEQE
Uniprot No.

Target Background

Function
Peptide chain release factor 1 terminates translation in response to the stop codons UAG and UAA.
Database Links
Protein Families
Prokaryotic/mitochondrial release factor family
Subcellular Location
Cytoplasm.

Q&A

What is Peptide chain release factor 1 (PrfA) and what is its function in E. coli?

Peptide chain release factor 1 (PrfA/RF1) is a critical protein involved in translation termination in bacteria. In E. coli, PrfA functions by recognizing specific stop codons (UAA and UAG) during protein synthesis and catalyzing the hydrolysis of the peptidyl-tRNA bond, releasing the newly synthesized polypeptide chain from the ribosome. PrfA is part of the bacterial release factor family, which includes RF1 (PrfA), RF2 (PrfB), and RF3 (PrfC) in the peptide release factor gene nomenclature . While RF1 and RF2 are class 1 release factors that recognize stop codons, RF3 is a class 2 release factor that enhances the activity of class 1 RFs and helps them dissociate from the ribosome .

How does PrfA recognize stop codons during translation?

PrfA recognizes the stop codons UAA ("ochre") and UAG ("amber") by binding to the A site of the ribosome in a manner that mimics tRNA binding . The protein's structure allows it to distinguish between stop codons and sense codons with high fidelity. The recognition involves specific interactions between PrfA's recognition domain and the nucleotides of the stop codon. PrfA binding to the ribosomal A site triggers the peptidyl transferase center to hydrolyze the ester bond between the completed polypeptide and the P-site tRNA, resulting in polypeptide release and eventual ribosome disassembly .

What are the key structural features of recombinant PrfA that contribute to its function?

Recombinant PrfA exhibits several important structural features that enable its function:

  • A domain organization that mimics tRNA shape to fit into the ribosomal A site

  • A highly conserved GGQ (Glycine-Glycine-Glutamine) motif essential for catalyzing peptidyl-tRNA hydrolysis

  • Specific recognition domains for interacting with UAA and UAG stop codons

  • A positively charged surface that facilitates interactions with the negatively charged ribosome components

  • Structured binding pockets that accommodate specific molecular interactions during termination

Electrostatic potential plays a significant role in PrfA function, with positively charged regions forming binding pockets important for molecular interactions, as demonstrated in similar release factors .

What expression systems yield the highest quality recombinant E. coli O81 PrfA for research applications?

For optimal expression of recombinant E. coli O81 PrfA, several systems have proven effective:

Expression SystemAdvantagesConsiderations
E. coli BL21(DE3)High protein yield, well-established protocolsMay require optimization for soluble expression
E. coli Rosetta strainsAddresses codon bias issuesHigher cost than standard BL21
Low-temperature induction systemsImproves protein folding and solubilityLonger expression time required
pET vector systems with His-tagsFacilitates purification via IMACTag may affect activity in some applications

The most successful approach typically involves expressing PrfA as a His-tagged fusion protein in E. coli, similar to other recombinant proteins described in the literature . Expression in E. coli provides the advantage of producing the protein in its native bacterial environment, potentially enhancing proper folding and activity.

What purification strategies yield highest activity for recombinant PrfA?

To maintain maximum activity during purification, researchers should consider the following protocol:

  • Initial capture using immobilized metal affinity chromatography (IMAC) with optimized imidazole concentrations for His-tagged PrfA

  • Secondary purification via ion exchange chromatography followed by size exclusion to enhance purity

  • Buffer optimization including stabilizing agents:

    • Tris/PBS-based buffer with 6% Trehalose at pH 8.0

    • Addition of 5-50% glycerol for long-term storage

  • Quality control assessment via SDS-PAGE to confirm purity >90%

  • Aliquoting to avoid repeated freeze-thaw cycles which reduce activity

Storage recommendations include maintaining the protein at -20°C/-80°C for long-term storage, with working aliquots kept at 4°C for up to one week . Reconstitution should be performed in deionized sterile water to a concentration of 0.1-1.0 mg/mL .

How can researchers accurately measure PrfA activity in vitro?

Several methodological approaches can be employed to assess PrfA activity:

  • Ribosomal Release Assays:

    • Pre-formed ribosome complexes with radiolabeled peptidyl-tRNA

    • Quantification of released peptides upon PrfA addition

    • Analysis via scintillation counting or gel electrophoresis

  • Fluorescence-Based Systems:

    • FRET-based reporters that change signal upon peptide release

    • Real-time monitoring of termination events

    • Quantifiable readout for kinetic measurements

  • In Vitro Translation Systems:

    • Complete translation reactions with reporter constructs

    • Comparison of termination efficiency at different stop codons

    • Measurement of full-length vs. terminated products

  • Electrostatic Interaction Analysis:

    • Assessment of the role of charged residues in binding pocket formation

    • Mutation of key lysine residues to evaluate their contribution to activity

    • Correlation between electrostatic potential and functional outcomes

These assays should include appropriate controls and be performed under physiologically relevant conditions to ensure reliable results.

How do mutations in key residues affect PrfA function and stop codon recognition?

Mutational analysis of PrfA reveals several critical regions that influence function:

  • GGQ Motif Mutations:

    • Substitutions in this catalytic motif severely reduce or abolish peptidyl-tRNA hydrolysis

    • Even conservative mutations significantly impact termination efficiency

  • Lysine Residues in Binding Pockets:

    • Mutations of key lysine residues like K64 and K122 can alter binding pocket electrostatics

    • K130 substitutions may completely abolish protein activity, as seen in analogous release factors

  • Recognition Domain Alterations:

    • Mutations affecting stop codon recognition may result in increased read-through

    • Some substitutions can create promiscuous recognition of non-cognate codons

  • Surface Charge Modifications:

    • Alterations in surface electrostatics can impact ribosome binding

    • The distribution of positive charge is critical for proper positioning within the ribosomal complex

Researchers using site-directed mutagenesis should carefully consider the structural context of each residue to predict functional outcomes.

How does the electrostatic potential distribution in PrfA contribute to its function?

Electrostatic modeling reveals crucial insights into PrfA function:

  • Release factors typically display distinct electrostatic potential distributions on their solvent-accessible surfaces, with positive charges (blue) and negative charges (red) arranged in functional patterns .

  • Key positively charged residues, particularly lysines, create binding pockets essential for molecular interactions. In analogous release factors, lysine residues such as K64 and K122 located at pocket edges and K130 positioned deep within the interior play critical roles .

  • The electrostatic potential range typically spans from -4kT/e (red) to +4 kT/e (blue), creating an electrical gradient that facilitates molecular recognition .

  • Positively charged DNA binding regions are often distinct from other functional domains in these proteins .

  • Mutations altering these electrostatic properties can significantly impact function, with substitutions of key lysine residues particularly detrimental to activity .

How can structural data about PrfA inform the development of functional models?

Structural analysis provides essential foundations for functional models of PrfA:

  • Crystal structure analysis reveals how binding pockets accommodate molecular interactions, as seen in related proteins where β-sheet-like interactions with peptide backbones occur .

  • Spacious tunnel pockets provide flexibility for molecular accommodation while maintaining selectivity for specific interactions .

  • Hydrophobic contributions from adjacent residues are often critical for inhibitory binding, creating selectivity mechanisms .

  • Parallel and antiparallel main-chain-main-chain contacts provide flexible sequence-independent binding capabilities .

  • Binding selectivity is often determined by specific residues capable of establishing hydrophobic contacts with defined pockets in the protein structure .

These structural insights enable researchers to develop detailed mechanistic models of how PrfA interacts with the ribosome and recognizes stop codons.

How can recombinant PrfA be used to study translation termination mechanisms?

Recombinant PrfA serves as a powerful tool for investigating translation termination:

  • Reconstituted Translation Systems:

    • Addition of purified PrfA to in vitro translation reactions

    • Systematic variation of components to identify essential factors

    • Manipulation of PrfA concentration to determine dose-dependent effects

  • Structure-Function Studies:

    • Engineering PrfA variants with altered specificity

    • Domain swapping between different release factors

    • Introduction of biophysical probes at specific positions

  • Interaction Analysis:

    • Investigation of PrfA binding to ribosomes in different states

    • Examination of competition between PrfA and suppressor tRNAs

    • Study of interactions with other translation factors

  • Evolutionary Studies:

    • Comparison of PrfA function across bacterial species

    • Reconstruction of ancestral release factor sequences

    • Analysis of coevolution between release factors and the translation machinery

How should researchers interpret kinetic data for PrfA-mediated peptide release?

Kinetic analysis of PrfA function requires careful consideration of several parameters:

  • Steady-State Kinetics:

    • Determination of kcat (turnover number) and Km (Michaelis constant)

    • Calculation of catalytic efficiency (kcat/Km) for comparing variants

    • Analysis of substrate specificity using different stop codon contexts

  • Pre-Steady-State Kinetics:

    • Investigation of initial binding events

    • Identification of rate-limiting steps

    • Detection of conformational changes during termination

  • Comparative Analysis Framework:

    • Evaluation of wild-type vs. mutant PrfA performance

    • Assessment of different stop codon termination efficiencies

    • Comparison of termination in different sequence contexts

  • Data Visualization and Interpretation:

    • Progress curves showing peptide release over time

    • Michaelis-Menten plots for parameter determination

    • Bar graphs comparing termination efficiency across conditions

When interpreting kinetic data, researchers should always consider the limitations of in vitro systems and how they might differ from the complex cellular environment.

What are the critical factors affecting the stability and activity of purified recombinant PrfA?

Several factors significantly impact PrfA stability and activity:

FactorOptimal ConditionsNotes
Temperature-20°C/-80°C for storage; 4°C for working solutionsAvoid repeated freeze-thaw cycles
Buffer compositionTris/PBS-based buffer, pH 8.06% Trehalose enhances stability
Additives5-50% glycerolDefault recommendation is 50%
Protein concentration0.1-1.0 mg/mLHigher concentrations may promote aggregation
HandlingBrief centrifugation before openingEnsures content collection at the bottom

For reconstitution, researchers should use deionized sterile water followed by addition of glycerol to the appropriate final concentration . Proper aliquoting is essential to avoid activity loss through repeated freezing and thawing.

How does PrfA activity in E. coli compare with other bacterial species, and what implications does this have for research?

Comparative analysis of PrfA across bacterial species reveals important evolutionary and functional insights:

  • The core function of stop codon recognition and peptide release is conserved, but specificity and efficiency can vary between species.

  • While E. coli PrfA (RF1) specifically recognizes UAA and UAG stop codons , homologs in other bacteria may show subtle differences in recognition efficiency or context preferences.

  • The fundamental mechanism involving a conserved GGQ motif for peptidyl-tRNA hydrolysis is maintained across diverse bacterial species.

  • In some pathogens like Listeria monocytogenes, proteins also named PrfA serve different functions as transcriptional activators regulating virulence genes rather than as release factors , highlighting the importance of distinguishing between similarly named but functionally distinct proteins.

  • Studying these differences provides valuable insights into the evolution of translation termination mechanisms and can inform the development of species-specific antibiotics targeting termination.

When conducting comparative studies, researchers must carefully consider species-specific optimization of expression conditions and functional assays.

What computational tools and approaches are most effective for studying PrfA interactions?

Several computational approaches facilitate the study of PrfA interactions:

  • Structural Analysis Tools:

    • Molecular visualization software (PyMOL, UCSF Chimera)

    • Binding site prediction algorithms

    • Molecular docking simulations

  • Electrostatic Analysis:

    • Calculation of electrostatic potential distributions on solvent-accessible surfaces

    • Mapping of charge distributions using color gradients from negative (red) to positive (blue)

    • Identification of functionally important charged residues

  • Molecular Dynamics Simulations:

    • Modeling of PrfA-ribosome interactions

    • Investigation of conformational changes during termination

    • Assessment of the impact of mutations on protein dynamics

  • Sequence-Based Analysis:

    • Multiple sequence alignment of release factors

    • Identification of conserved motifs and critical residues

    • Phylogenetic analysis to understand evolutionary relationships

  • Integrated Approaches:

    • Combining structural data with functional assays

    • Correlating computational predictions with experimental results

    • Machine learning methods to predict interaction specificity

These computational methods complement experimental approaches and can guide the design of hypothesis-driven research into PrfA function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.